# FORE Biotherapeutics

**Source:** https://www.startuphub.ai/startups/novellusdx
**Profile type:** Startup

> Precision oncology company developing cancer therapies guided by proprietary functional genomics.

## About

FORE Biotherapeutics is a precision oncology company dedicated to pioneering the development of novel cancer therapies. Their approach is deeply rooted in science and innovation, utilizing proprietary functional genomics to guide their therapeutic development. Their vision is to compassionately contribute to solving cancer.

## Key facts

- **Slug:** novellusdx
- **Website:** http://fore.bio
- **Location:** Philadelphia, United States
- **Founded:** 2011-01-01 00:00:00
- **Employees:** 56
- **Operating status:** Active
- **Total funding:** $232M
- **Sectors / tags:** Healthcare, Drug Development, Genomics, Next Generation Sequencing, Biotech, Oncology, Clinical, Drug Discovery, Precision Medicine, Therapeutics, Clinical Trials
- **Social:**
  - LinkedIn: https://www.linkedin.com/company/forebiotherapeutics/
  - Twitter: https://twitter.com/forebiotx

## Frequently asked

### What does FORE Biotherapeutics do?

FORE Biotherapeutics is a precision oncology company dedicated to pioneering the development of novel cancer therapies. Their approach is deeply rooted in science and innovation, utilizing proprietary functional genomics to guide their therapeutic development. Their vision is to compassionately contribute to solving cancer. (formerly NovellusDX.)

### What is FORE Biotherapeutics's revenue?

StartupHub estimates FORE Biotherapeutics's annual revenue at $10.5M (range $5.8M to $24.3M, 66% confidence), based on comparable companies in the sector.

### What is FORE Biotherapeutics's valuation?

StartupHub estimates FORE Biotherapeutics's effective valuation at $76.1M (range $53.3M to $98.9M, 42% confidence), based on comparable companies in the sector.

### How much funding has FORE Biotherapeutics raised?

FORE Biotherapeutics has raised a total of $232M in funding. The most recent round on record is Series D-2 Extension.

### Where is FORE Biotherapeutics headquartered?

FORE Biotherapeutics is headquartered in Philadelphia, United States.

### When was FORE Biotherapeutics founded?

FORE Biotherapeutics was founded in 2011.

### What industry does FORE Biotherapeutics operate in?

FORE Biotherapeutics operates in Healthcare, Drug Development, Genomics, Next Generation Sequencing, Biotech, Oncology.

### How many employees does FORE Biotherapeutics have?

FORE Biotherapeutics has approximately 56 people on record.

## JSON-LD

Structured data aligned with this page's `<script type="application/ld+json">` (included when the profile is server-rendered).

```json
{
  "@context": "https://schema.org",
  "@graph": [
    {
      "@type": "BreadcrumbList",
      "itemListElement": [
        {
          "@type": "ListItem",
          "position": 1,
          "name": "Home",
          "item": "https://www.startuphub.ai"
        },
        {
          "@type": "ListItem",
          "position": 2,
          "name": "Startups",
          "item": "https://www.startuphub.ai/startups"
        },
        {
          "@type": "ListItem",
          "position": 3,
          "name": "FORE Biotherapeutics",
          "item": "https://www.startuphub.ai/startups/novellusdx"
        }
      ]
    },
    {
      "@type": "ProfilePage",
      "@id": "https://www.startuphub.ai/startups/novellusdx#webpage",
      "url": "https://www.startuphub.ai/startups/novellusdx",
      "name": "FORE Biotherapeutics - AI Startup Profile | StartupHub.ai",
      "description": "This is the official profile of FORE Biotherapeutics (formerly NovellusDX). FORE Biotherapeutics is a startup founded in 2011, operating in Healthcare and Drug Development. Precision oncology company developing cancer therapies guided by proprietary functional genomics. Headquartered in Philadelphia, United States. The company has approximately 56 employees.",
      "dateModified": "2026-08-01T09:45:08.12+00:00",
      "mainEntity": {
        "@id": "https://www.startuphub.ai/startups/novellusdx#organization"
      }
    },
    {
      "@type": "Organization",
      "@id": "https://www.startuphub.ai/startups/novellusdx#organization",
      "name": "FORE Biotherapeutics",
      "url": "http://fore.bio",
      "logo": "https://cdn.startuphub.ai/storage/v1/object/public/entity-images/logos/e0e83e6f-99f7-4762-b950-a50280c88f1b-square.webp",
      "image": "https://cdn.startuphub.ai/storage/v1/object/public/entity-images/logos/e0e83e6f-99f7-4762-b950-a50280c88f1b-square.webp",
      "description": "This is the official profile of FORE Biotherapeutics (formerly NovellusDX). FORE Biotherapeutics is a startup founded in 2011, operating in Healthcare and Drug Development. Precision oncology company developing cancer therapies guided by proprietary functional genomics. Headquartered in Philadelphia, United States. The company has approximately 56 employees.",
      "sameAs": [
        "https://www.linkedin.com/company/forebiotherapeutics/",
        "https://twitter.com/forebiotx",
        "https://www.startuphub.ai/startups/novellusdx"
      ],
      "foundingDate": "2011-01-01 00:00:00",
      "numberOfEmployees": {
        "@type": "QuantitativeValue",
        "value": 56
      },
      "address": {
        "@type": "PostalAddress",
        "addressLocality": "Philadelphia",
        "addressCountry": "US"
      },
      "knowsAbout": [
        "Healthcare",
        "Drug Development",
        "Genomics",
        "Next Generation Sequencing",
        "Biotech",
        "Oncology",
        "Clinical",
        "Drug Discovery",
        "Precision Medicine",
        "Therapeutics",
        "Clinical Trials"
      ]
    },
    {
      "@type": "Product",
      "@id": "https://www.startuphub.ai/startups/novellusdx#profile-assessment",
      "name": "FORE Biotherapeutics - StartupHub.ai Profile Assessment",
      "url": "https://www.startuphub.ai/startups/novellusdx",
      "image": "https://cdn.startuphub.ai/storage/v1/object/public/entity-images/logos/e0e83e6f-99f7-4762-b950-a50280c88f1b-square.webp",
      "category": "Healthcare",
      "description": "This is the official profile of FORE Biotherapeutics (formerly NovellusDX). FORE Biotherapeutics is a startup founded in 2011, operating in Healthcare and Drug Development. Precision oncology company developing cancer therapies guided by proprietary functional genomics. Headquartered in Philadelphia, United States. The company has approximately 56 employees. Agent Readiness score: 40/100. Full audit: https://www.startuphub.ai/startups/novellusdx/agent-readiness",
      "brand": {
        "@type": "Brand",
        "name": "FORE Biotherapeutics"
      },
      "review": {
        "@type": "Review",
        "author": {
          "@type": "Organization",
          "name": "StartupHub.ai"
        },
        "datePublished": "2026-08-01",
        "name": "FORE Biotherapeutics - Profile Score 55/100",
        "reviewBody": "This is the official profile of FORE Biotherapeutics (formerly NovellusDX). FORE Biotherapeutics is a startup founded in 2011, operating in Healthcare and Drug Development. Precision oncology company developing cancer therapies guided by proprietary functional genomics. Headquartered in Philadelphia, United States. The company has approximately 56 employees. Agent Readiness score: 40/100. Full audit: https://www.startuphub.ai/startups/novellusdx/agent-readiness",
        "reviewRating": {
          "@type": "Rating",
          "ratingValue": 55,
          "bestRating": 100,
          "worstRating": 0
        }
      }
    }
  ]
}
```